Abdo WF, Bloem BR, Kremer HP, Lammers GJ, Verbeek MM, Overeem S. CSF hypocretin-1 levels are normal in multiple-system atrophy. Parkinsonism Relat Disord 2008; 14: 342-4.
Anderson T, Luxon L, Quinn N, Daniel S, Marsden CD, Bronstein A. Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients. Mov Disord 2008; 23: 977-84.
Benarroch EE, Schmeichel AM, Low PA, Sandroni P, Parisi JE. Loss of A5 noradrenergic neurons in multiple system atrophy. Acta Neuropathol 2008; 115: 629-34.
Ben-Menachem E, Wikkelso C. Retraction. Cardiovascular dysautonomia in Parkinson's disease and multiple system atrophy. Acta Neurol Scand 2008; 118: 208.
Bhidayasiri R, Ling H. Multiple system atrophy. Neurologist 2008; 14: 224-37.
Donadio V, Nolano M, Elam M, Montagna P, Provitera V, Bugiardini E, et al. Anhidrosis in multiple system atrophy: a preganglionic sudomotor dysfunction? Mov Disord 2008; 23: 885-8.
Endo K, Shirai K, Sakakibara R. Multiple system atrophy and the syndrome of inappropriate secretion of antidiuretic hormone. Mov Disord 2008; 23: 1325-6.
Feng T, Wang Y, Ouyang Q, Duan Z, Li W, Lu L, et al. Comparison of cerebral glucose metabolism between multiple system atrophy Parkinsonian type and Parkinson's disease. Neurol Res 2008; 30: 377-82.
Fletcher WA. Eye signs in patients with parkinsonism: do they predict the development of multiple system atrophy? Nat Clin Pract Neurol 2008; 4: 540-1.
Fujishiro H, Ahn TB, Frigerio R, DelleDonne A, Josephs KA, Parisi JE, et al. Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy? Acta Neuropathol 2008; 116: 269-75.
Gaig C, Iranzo A, Tolosa E, Vilaseca I, Rey MJ, Santamaria J. Pathological description of a non-motor variant of multiple system atrophy. J Neurol Neurosurg Psychiatry 2008; 79: 1399-400.
Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71: 670-6.
Goldstein DS, Holmes C, Bentho O, Sato T, Moak J, Sharabi Y, et al. Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy. Parkinsonism Relat Disord 2008; 14: 600-7.
Hardy J. Multiple system atrophy: pathophysiology, treatment and nursing care. Nurs Stand 2008; 22: 50-6; quiz 58.
Hashimoto M, Kawasaki K, Suzuki M, Mitani K, Murayama S, Mishina M, et al. Presynaptic and postsynaptic nigrostriatal dopaminergic functions in multiple system atrophy. Neuroreport 2008; 19: 145-50.
Heo JH, Lee ST, Chu K, Kim M. The efficacy of combined estrogen and buspirone treatment in olivopontocerebellar atrophy. J Neurol Sci 2008; 271: 87-90.
Honjo Y, Shirakashi Y, Kawamoto Y, Akiguchi I. Anti-DARPP32 antibody-immunopositive inclusions in the brain of patients with multiple system atrophy. Clin Neuropathol 2008; 27: 309-16.
Huang KJ, Tsai CH. Slit sign of magnetic resonance image in multiple system atrophy. Acta Neurol Taiwan 2008; 17: 74.
Huang Y, Song YJ, Murphy K, Holton JL, Lashley T, Revesz T, et al. LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions. Acta Neuropathol 2008; 116: 639-46.
Ishizawa K, Komori T, Arai N, Mizutani T, Hirose T. Glial cytoplasmic inclusions and tissue injury in multiple system atrophy: A quantitative study in white matter (olivopontocerebellar system) and gray matter (nigrostriatal system). Neuropathology 2008; 28: 249-57.
Ito M, Watanabe H, Atsuta N, Senda J, Kawai Y, Tanaka F, et al. Fractional anisotropy values detect pyramidal tract involvement in multiple system atrophy. J Neurol Sci 2008; 271: 40-6.
Kawai Y, Suenaga M, Takeda A, Ito M, Watanabe H, Tanaka F, et al. Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P. Neurology 2008; 70: 1390-6.
Kollensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, et al. Red flags for multiple system atrophy. Mov Disord 2008; 23: 1093-9.
Kwon KY, Choi CG, Kim JS, Lee MC, Chung SJ. Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease. Eur J Neurol 2008; 15: 1043-9.
Lambrecq V, Krim E, Meissner W, Guehl D, Tison F. [Deep-brain stimulation of the internal pallidum in multiple system atrophy]. Rev Neurol (Paris) 2008; 164: 398-402.
Lee PH, An YS, Yong SW, Yoon SN. Cortical metabolic changes in the cerebellar variant of multiple system atrophy: a voxel-based FDG-PET study in 41 patients. Neuroimage 2008; 40: 796-801.
Lee PH, Kim JW, Bang OY, Ahn YH, Joo IS, Huh K. Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. Clin Pharmacol Ther 2008; 83: 723-30.
Lee PH, Lee G, Paik MJ. Polyunsaturated fatty acid levels in the cerebrospinal fluid of patients with Parkinson's disease and multiple system atrophy. Mov Disord 2008; 23: 309-10.
Liang Y, Li S, Wen C, Zhang Y, Guo Q, Wang H, et al. Intrastriatal injection of colchicine induces striatonigral degeneration in mice. J Neurochem 2008; 106: 1815-27.
Liao YS, Lin FL. [The nursing experience of a patient with parkinsonian type of multiple system atrophy]. Hu Li Za Zhi 2008; 55: 93-100.
Lu CS, Chang HC, Weng YH, Chen RS, Bonifati V, Wu-Chou YH. Analysis of the LRRK2 Gly2385Arg variant in primary dystonia and multiple system atrophy in Taiwan. Parkinsonism Relat Disord 2008; 14: 393-6.
Luo W, Ouyang Z, Guo Y, Chen Y, Ding M. Spinal muscular atrophy combined with sporadic olivopontocerebellar atrophy. Clin Neurol Neurosurg 2008; 110: 855-8.
Lyoo CH, Jeong Y, Ryu YH, Lee SY, Song TJ, Lee JH, et al. Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy. Brain 2008; 131: 438-46.
Massano J, Costa F, Nadais G. Teaching neuroImage: MRI in multiple system atrophy: "hot cross bun" sign and hyperintense rim bordering the putamina. Neurology 2008; 71: e38.
Matsusue E, Fujii S, Kanasaki Y, Sugihara S, Miyata H, Ohama E, et al. Putaminal lesion in multiple system atrophy: postmortem MR-pathological correlations. Neuroradiology 2008; 50: 559-67.
Mochizuki Y, Mizutani T, Warabi Y, Shimizu T, Isozaki E. The somatosensory cortex in multiple system atrophy. J Neurol Sci 2008; 271: 174-9.
Nagayama H, Yamazaki M, Ueda M, Nishiyama Y, Hamamoto M, Katayama Y, et al. Low myocardial MIBG uptake in multiple system atrophy with incidental Lewy body pathology: an autopsy case report. Mov Disord 2008; 23: 1055-7.
Oishi K, Konishi J, Mori S, Ishihara H, Kawamitsu H, Fujii M, et al. Reduced Fractional Anisotropy in Early-Stage Cerebellar Variant of Multiple System Atrophy. J Neuroimaging 2008.
Oka H, Mochio S, Yoshioka M, Morita M, Onouchi K, Inoue K. Retraction. Cardiovascular dysautonomia in Parkinson's disease and multiple system atrophy. Acta Neurol Scand 2008; 118: 208.
O'Sullivan SS, Holton JL, Massey LA, Williams DR, Revesz T, Lees AJ. Parkinson's disease with Onuf's nucleus involvement mimicking multiple system atrophy. J Neurol Neurosurg Psychiatry 2008; 79: 232-4.
O'Sullivan SS, Massey LA, Williams DR, Silveira-Moriyama L, Kempster PA, Holton JL, et al. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 2008; 131: 1362-72.
Oyama T, Shirai K, Sakakibara R, Kishi M, Ogawa E, Suzuki Y. Multiple system atrophy and impaired gallbladder emptying. Mov Disord 2008; 23: 1321-2.
Papatsoris AG, Papapetropoulos S, Singer C, Deliveliotis C. Urinary and erectile dysfunction in multiple system atrophy (MSA). Neurourol Urodyn 2008; 27: 22-7.
Paudel B, Paudel K, Paudel R, Pandru K. Parkisonism with Shy-Drager syndrome--a case report. Nepal Med Coll J 2008; 10: 68-71.
Quattrone A, Nicoletti G, Messina D, Fera F, Condino F, Pugliese P, et al. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 2008; 246: 214-21.
Quinn N, Barker RA, Wenning GK. Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective? Clin Pharmacol Ther 2008; 83: 663-5.
Sachin S, Shukla G, Goyal V, Singh S, Aggarwal V, Behari M. Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy. Neurol India 2008; 56: 122-6.
Schmeichel AM, Buchhalter LC, Low PA, Parisi JE, Boeve BW, Sandroni P, et al. Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy. Neurology 2008; 70: 368-73.
Schmidt C, Herting B, Prieur S, Junghanns S, Schweitzer K, Globas C, et al. Autonomic dysfunction in different subtypes of multiple system atrophy. Mov Disord 2008; 23: 1766-72.
Schrader C, Peschel T, Dauper J, Rollnik JD, Dengler R, Kossev AR. Changes in processing of proprioceptive information in Parkinson's disease and multiple system atrophy. Clin Neurophysiol 2008; 119: 1139-46.
Schrag A, Wenning GK, Quinn N, Ben-Shlomo Y. Survival in multiple system atrophy. Mov Disord 2008; 23: 294-6.
Shibao C, Garland EM, Gamboa A, Vnencak-Jones CL, Van Woeltz M, Haines JL, et al. PRNP M129V homozygosity in multiple system atrophy vs. Parkinson's disease. Clin Auton Res 2008; 18: 13-9.
Shimohata T, Ozawa T, Nakayama H, Tomita M, Nishizawa M. Tracheostomy can fatally exacerbate sleep-disordered breathing in multiple system atrophy. Neurology 2008; 70: 980-1; author reply 981-2.
Shimohata T, Ozawa T, Nakayama H, Tomita M, Shinoda H, Nishizawa M. Frequency of nocturnal sudden death in patients with multiple system atrophy. J Neurol 2008; 255: 1483-5.
Silber MH. Tracheostomy can fatally exacerbate sleep-disordered breathing in multiple system atrophy. Neurology 2008; 70: 980; author reply 981-2.
Soma H, Yabe I, Takei A, Fujiki N, Yanagihara T, Sasaki H. Associations between multiple system atrophy and polymorphisms of SLC1A4, SQSTM1, and EIF4EBP1 genes. Mov Disord 2008; 23: 1161-7.
Song IU, Kim JS, Lee KS. Dopa-responsive camptocormia in a patient with multiple system atrophy. Parkinsonism Relat Disord 2008; 14: 161-3.
Stefanova N, Poewe W, Wenning GK. Rasagiline is neuroprotective in a transgenic model of multiple system atrophy. Exp Neurol 2008; 210: 421-7.
Suzuki K, Asahina M, Suzuki A, Hattori T. Cerebral oxygenation monitoring for detecting critical cerebral hypoperfusion in patients with multiple system atrophy during the head-up tilt test. Intern Med 2008; 47: 1681-7.
Suzuki K, Miyamoto T, Miyamoto M, Hirata K. Nocturnal hypersalivation caused by distigmine bromide in a patient with multiple system atrophy. Intern Med 2008; 47: 983-4.
Ubhi K, Rockenstein E, Mante M, Patrick C, Adame A, Thukral M, et al. Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy. Neuroreport 2008; 19: 1271-6.
Vidal JS, Vidailhet M, Elbaz A, Derkinderen P, Tzourio C, Alperovitch A. Risk factors of multiple system atrophy: a case-control study in French patients. Mov Disord 2008; 23: 797-803.
Wang H, Cui LY, Du H, Li BH, Liu MS, Guan YZ. [Value of anal sphincter electromyography, orthostatic hypotension and dizziness in diagnosing multiple system atrophy]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2008; 30: 668-71.
Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG. Multiple system atrophy: a primary oligodendrogliopathy. Ann Neurol 2008; 64: 239-46.
Zesiewicz TA, Sullivan KL, Gooch CL. Red flags to spot the parkinsonian variant of multiple system atrophy. Nat Clin Pract Neurol 2008; 4: 596-7.